Dermacare retrospect and Dmedcare prospect.
Dermacare is an excellent manufacturer of the medical device with QMS certification whose registered items include:
◎Laser instruments for general surgery, plastic surgery, and dermatology
◎Electrotome and its accessories for cutting and hemostasis
◎Automated external defibrillator (AED)
Among them, AED cumulative sales have exceeded 2000 units since have been launched in 2019.
Because the trend of aesthetic medicine has gradually shifted from equipment to consumables, cooperated with HUGEL Inc. to introduce the Letybo (Baotila), which holds a 40% market share in Korea.
There were three major brands shared the Botox market in Taiwan: Botox in the United States, Dysport in the United Kingdom, and Xeomin in Germany previously; However, the Korean Letybo (Baotila)entered the Taiwan market and broke the market situation, which held a market share of more than 15% and caught up the Botox in less than two years.
The Hyaluronate Injections device (known as an intradermal injection or vital injector) was popularized with aesthetic clinics in dozens of countries, Dermacare obtained approval from the Ministry of Health and Welfare in April 2021, which is not only safe and effective but also protects consumers.